Shruti U Gandhy (Shruti Gandhy)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Regulatory T Cells

Endoplasmic Reticulum Stress

Metastatic Colorectal Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Sriram Subramaniam, Hong Zhao, Miao Zhao, Youwei Bi, Guansheng Liu, Jianghong Fan, Oluseyi Adeniyi, Rosane Charlab, Dubravka Kufrin, Matthew D Thompson, Kristin Jarrell, Doris Auth, Steven J Lemery, Richard Pazdur, Paul G Kluetz, Lola A Fashoyin-Aje
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jason Mark Redman, Yo-Ting Tsai, Benjamin A Weinberg, Renee N Donahue, Shruti U Gandhy, Margaret E Gatti-Mays, Houssein Abdul Sater, Marijo Bilusic, Lisa M Cordes, Seth M Steinberg, Jennifer L Marte, Caroline Jochems, Sunnie S Kim, John L Marshall, Sheri McMahon, Erica Redmond, Jeffrey Schlom, James L Gulley, Julius Strauss
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer. The oncologist 27 (3) (2022)
Shruti U Gandhy, Ravi A Madan, Jeanny B Aragon-Ching
The immunotherapy revolution in genitourinary malignancies. Immunotherapy 12 (11) (2020)